<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1498413</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association between self-reported eye conditions in patients at rural federally qualified health centers and vision-targeted health-related quality of life: the AL-SIGHT study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Swain</surname> <given-names>Thomas A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>McGwin</surname> <given-names>Gerald</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Rhodes</surname> <given-names>Lindsay A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Girkin</surname> <given-names>Christopher A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Owsley</surname> <given-names>Cynthia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1486761/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham</institution>, <addr-line>Birmingham, AL</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Epidemiology, School of Public Health, University of Alabama at Birmingham</institution>, <addr-line>Birmingham, AL</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Silvio Ionta, Fondation Asile des aveugles, Switzerland</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Jacqueline Chua, Singapore National Eye Center, Singapore</p>
<p>Sebasti&#x00E3;o Cronemberger, Federal University of Minas Gerais, Brazil</p>
<p>Suzana Konjevoda, General Hospital Zadar, Croatia</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Cynthia Owsley, <email>cynthiaowsley@uabmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1498413</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Swain, McGwin, Rhodes, Girkin and Owsley.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Swain, McGwin, Rhodes, Girkin and Owsley</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Federally Qualified Health Centers (FQHCs) are safety-net primary health care clinics in the US serving medically underserved areas and populations. We administered the National Eye Institute Visual Function Questionnaire &#x2013; 9 (VFQ-9), a vision-targeted, health-related quality of life questionnaire, to patients in 3 FQHCs in rural Alabama at risk for glaucoma. We examined demographic factors and self-reported eye conditions associated with VFQ-9 scores.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>The VFQ-9 (score range 0&#x2013;100) was administered to patients at-risk for glaucoma including African Americans or Hispanics &#x2265;40&#x202F;years, white persons &#x2265;50&#x202F;years, persons with diabetes &#x2265;18&#x202F;years, &#x2265;18&#x202F;years with glaucoma or glaucoma suspect, and/or&#x202F;&#x2265;&#x202F;18&#x202F;years with a family history of glaucoma. Demographic variables were collected -- age, gender, race/ethnicity, employment, marital status, health insurance, education, and driving status. Patients reported the presence of eye conditions including glaucoma and many other eye conditions. Stepwise linear regression modeled which variables accounted for the greatest variance of the VFQ-9 score.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>Composite VFQ-9 scores averaged 82.4. The best fitting model for VFQ-9 scores included being a driver, insurance type/status, self-reported glaucoma or glaucoma suspect, blurry vision, and double vision.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Patients at-risk for glaucoma seeking care at FQHCs in rural Alabama have moderate impairment in quality of life as assessed by the VFQ-9. Factors negatively influencing scores are self-reported glaucoma or glaucoma suspect, blurry vision, double vision, not being a driver, and having no health insurance. The VFQ-9 is a good candidate as a vision-targeted quality of life outcome for eye health interventions at rural FQHCs in those with glaucoma.</p>
</sec>
</abstract>
<kwd-group>
<kwd>federally qualified health center</kwd>
<kwd>glaucoma</kwd>
<kwd>rural health</kwd>
<kwd>quality of life</kwd>
<kwd>National Eye Institute Visual Function Questionnaire-9</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="8"/>
<word-count count="5327"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ophthalmology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Federally Qualified Health Centers (FQHCs) are safety-net primary health care clinics in the United States designed to serve medically underserved areas and populations in both rural and urban regions. They provide services regardless of the patient&#x2019;s ability to pay, using a sliding-scale fee based on the ability to pay. While they provide primary medical care in many health domains, one domain that is not well addressed by FQHCs is eye care. A recent report by the National Academies of Science, Engineering and Medicine indicated that primary eye care services (through optometrists or ophthalmologists) are rarely available at FQHCs; the report provided an estimate that less than 3% of FQHC patients actually receive vision care services at FQHCs, representing 0.89% of FQHC clinic visits (<xref ref-type="bibr" rid="ref1">1</xref>).</p>
<p>An important question is whether telemedicine services could address this significant need in rural areas by combining this technology with FQHC primary care services to optimize a practical and cost-effective screening strategy to identify eye conditions. In telemedicine, the patient&#x2019;s screening information is electronically sent from the FQHC to a remote ophthalmologist for diagnosis who makes a recommendation for follow-up referral as needed. In addition, with the emergence of non-invasive ocular imaging tools with higher diagnostic reliability, electronic transferability, and ease of use, telemedicine has shown promise as compared to in-person diagnosis of diabetic retinopathy, age-related macular degeneration, and glaucoma (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). The COVID-19 pandemic heightened the need for telemedicine, and thus the rise in its use since the pandemic (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
<p>Recently we conducted a telemedicine screening program based in three FQHCs located in rural Alabama areas called Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT) (<xref ref-type="bibr" rid="ref5">5</xref>). We focused on patients who were at-risk for glaucoma associated disease (GAD), which includes glaucoma, ocular hypertension, and glaucoma suspect. The at-risk population for GAD includes White persons &#x2265;50&#x202F;years of age, African American and Hispanic people &#x2265;40&#x202F;years of age, and people with a family history of GAD and/or diabetes (<xref ref-type="bibr" rid="ref6">6</xref>). Before we performed the vision screening, we queried patients&#x2019; demographics and own awareness of any eye conditions they had using a self-report structured questionnaire. In addition, we also administered a short-form version of a commonly used vision-targeted, health-related quality of life questionnaire. The purpose of this analysis was to examine the association between vision-targeted quality of life and patient demographics and self-awareness about eye conditions at these FQHCs.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2</label>
<title>Methods</title>
<p>This study was approved by the Institutional Review Board of the University of Alabama at Birmingham and adhered to the tenets of the Declaration of Helsinki. Participants provided written informed consent after the nature and purpose of the study was explained.</p>
<sec id="sec7">
<label>2.1</label>
<title>Data source</title>
<p>The three FQHC sites were part of the Cahaba Medical Care Foundation, an Alabama-based FQHC, and are located in rural areas. These FQHCs provide health care for approximately 16,000 patients per year, over half of whom are African American. Fifty-five percent of their patient population have Medicaid or Medicare, 25% have private insurance and 20% are uninsured. The study clinics are in the following Alabama towns: Centreville (Bibb County), Maplesville (Chilton County), and Marion (Perry County). This region of Alabama borders or is part of the region known as the Black Belt named for its rich black soil that supported cotton agriculture for many decades. In the 19th century, the agricultural workers were enslaved African Americans. The Black Belt consists of 9 of 10 of the poorest counties in the state. Poverty is directly linked to health disparities in the Black Belt (<xref ref-type="bibr" rid="ref7">7</xref>). Today this region&#x2019;s population is over 50% African American.</p>
<p>Patients presenting at these clinics were eligible to participate in the study if they had one or more risk factors for GAD and volunteered to participate: (1) African American or Hispanic &#x2265;40&#x202F;years of age; (2) White persons &#x2265;50&#x202F;years of age; (3) anyone &#x2265;18&#x202F;years of age with diabetes, (4) anyone &#x2265;18&#x202F;years of age with a GAD; and (5) anyone &#x2265;18&#x202F;years of age with a family history of glaucoma. All participants spoke and understood English. Although the inclusion criteria are focused on patients at-risk for glaucoma, we asked about whether they had many eye conditions as described below. All structured questionnaires were interviewer-administered.</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Protocol</title>
<p>Questionnaires addressed the following: birthdate, sex, race/ethnicity, employment status, marital status, health insurance status, educational level attained, and the transportation used to attend the screening. We also asked participants whether they had any of the following eye conditions before they learned the results of their vision screening: glaucoma or glaucoma suspect, refractive error (defined as near-sightedness, far-sightedness, astigmatism, presbyopia), dry eye, blurry vision, double vision, cataract, high eye pressure, diabetic retinopathy, age-related macular degeneration, and floaters. Response options were yes versus no.</p>
<p>We also administered the short-form of the National Eye Institute Visual Function Questionnaire &#x2013; 25 (NEI VFQ-25), a vision-targeted health-related quality of life questionnaire (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref9">9</xref>). The National Eye Institute Visual Function Questionnaire - 9 (NEI VFQ-9) (<xref ref-type="bibr" rid="ref10">10</xref>) has demonstrated excellent reliability and validity (<xref ref-type="table" rid="tab1">Table 1</xref>). Content domains addressed are general vision, near and distance activities, mental health, role difficulties, driving, and peripheral vision. Values ranging from 0 to 100 were assigned to response options for each question as indicated by the NEI VFQ-25 scoring methods (<xref ref-type="bibr" rid="ref11">11</xref>). Higher values correspond to better functioning and quality of life. Each question comprised a single subscale except near vision, for which the mean of 3 items made the subscale. The composite score was an average of all subscales. If persons were no longer driving or never drove, the composite was the mean of the other 6 subscales.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Items in the National Eye Institute Visual Function Questionnaire &#x2013; 9 (NEI VFQ-9) (<xref ref-type="bibr" rid="ref10">10</xref>).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Item</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Q1. At the present time, would you say your eyesight (with glasses or contact lenses, if you wear them) is:</td>
</tr>
<tr>
<td align="left" valign="top">(1) Excellent, (2) good, (3) fair, (4) poor, (5) very poor, or (6) are you completely blind?</td>
</tr>
<tr>
<td align="left" valign="top">Q2. How much of the time do you worry about your eyesight?</td>
</tr>
<tr>
<td align="left" valign="top">(1) None of the time, (2) a little of time, (3) some of the time, (4) most of the time, or (5) all of the time.</td>
</tr>
<tr>
<td align="left" valign="top">Q3. How much difficulty do you have reading ordinary print in newspapers?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, (5) stopped doing because of your eyesight, or (6) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
<tr>
<td align="left" valign="top">Q4. How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, (5) stopped doing because of your eyesight, or (6) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
<tr>
<td align="left" valign="top">Q5. Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, (5) stopped doing because of your eyesight, or (6) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
<tr>
<td align="left" valign="top">Q6. How much difficulty do you have driving during the daytime in familiar places?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, stopped doing because of your eyesight, or (5) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
<tr>
<td align="left" valign="top">Q7. Are you limited in how long you can walk or do other activities such as housework, child care, school, or community activities because of your vision?</td>
</tr>
<tr>
<td align="left" valign="top">(1) All of the time, (2) most of the time, (3) some of the time, (4) a little of time, or (5) none of the time.</td>
</tr>
<tr>
<td align="left" valign="top">Q8. Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, (5) stopped doing because of your eyesight, or (6) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
<tr>
<td align="left" valign="top">Q9. Because of your eyesight, how much difficulty do you have finding something on a crowded shelf?</td>
</tr>
<tr>
<td align="left" valign="top">(1) No difficulty at all, (2) a little difficulty, (3) moderate difficulty, (4) extreme difficulty, (5) stopped doing because of your eyesight, or (6) stopped doing this for other reasons or not interested in doing this.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Response options are listed below each item.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Statistical analysis</title>
<p>Mean (standard deviation) and number (percent) were used to summarize continuous and categorical variables, respectively. The VFQ-9 composite score was compared by participant characteristics and self-reported eye conditions using linear regression adjusting for age (except the comparison by age category). The level of significance was <italic>p</italic>&#x202F;&#x2264;&#x202F;0.05 (two-sided). To model which variables accounted for the greatest variance of the VFQ-9 score, meaning the participant factors which statistically explained the score value, stepwise linear regression was completed for demographics and other characteristics, self-reported eye conditions, and both of these data groupings combined. The <italic>p</italic>-value was set to 0.05 for model entry and 0.01 to stay in the model. Corrected Akaike information criterion (AICC) and adjusted R<sup>2</sup> values were examined in the modeling process. Models with higher adjusted R<sup>2</sup> have greater accuracy and explained variance. AICCs are relative indices used in model selection and reflect goodness of fit, with lower values indicative of a more parsimonious model. All analyses were conducted in SAS, version 9.4 (SAS Institute, Cary, NC).</p>
</sec>
</sec>
<sec sec-type="results" id="sec10">
<label>3</label>
<title>Results</title>
<p>A total of 500 persons enrolled and comprised the analysis sample across the three FQHC clinics. Over 90% of participants were&#x202F;&#x2265;&#x202F;40&#x202F;years old, with 2/3 women (<xref ref-type="table" rid="tab2">Table 2</xref>). African Americans and white persons were approximately equally represented. Those who were unemployed represented 38.6% of the sample. Over half were married or had a domestic partner. With respect to health insurance, 45.6% had Medicaid or Medicare, with 18.2% with no health insurance; 23.9% did not complete high school.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Demographic characteristics of the sample (<italic>N</italic>&#x202F;=&#x202F;500).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top"><italic>n</italic> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="2">Age, years</td>
</tr>
<tr>
<td align="left" valign="top">18&#x2013;39</td>
<td align="center" valign="top">43 (8.6)</td>
</tr>
<tr>
<td align="left" valign="top">40&#x2013;59</td>
<td align="center" valign="top">247 (49.4)</td>
</tr>
<tr>
<td align="left" valign="top">&#x2265; 60</td>
<td align="center" valign="top">210 (42.0)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Gender</td>
</tr>
<tr>
<td align="left" valign="top">Men</td>
<td align="center" valign="top">178 (35.6)</td>
</tr>
<tr>
<td align="left" valign="top">Women</td>
<td align="center" valign="top">322 (64.4)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Race</td>
</tr>
<tr>
<td align="left" valign="top">African American</td>
<td align="center" valign="top">228 (45.6)</td>
</tr>
<tr>
<td align="left" valign="top">White persons</td>
<td align="center" valign="top">258 (51.6)</td>
</tr>
<tr>
<td align="left" valign="top">Other<sup>1</sup></td>
<td align="center" valign="top">14 (2.8)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Employment</td>
</tr>
<tr>
<td align="left" valign="top">Employed full- or part-time</td>
<td align="center" valign="top">171 (34.2)</td>
</tr>
<tr>
<td align="left" valign="top">Retired</td>
<td align="center" valign="top">136 (27.2)</td>
</tr>
<tr>
<td align="left" valign="top">Unemployed or unable to work</td>
<td align="center" valign="top">193 (38.6)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Marital status</td>
</tr>
<tr>
<td align="left" valign="top">Married or domestic partnership</td>
<td align="center" valign="top">255 (51.0)</td>
</tr>
<tr>
<td align="left" valign="top">Divorced, separated, or single</td>
<td align="center" valign="top">190 (38.0)</td>
</tr>
<tr>
<td align="left" valign="top">Widowed</td>
<td align="center" valign="top">55 (11.0)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Health insurance</td>
</tr>
<tr>
<td align="left" valign="top">Medicaid</td>
<td align="center" valign="top">101 (20.2)</td>
</tr>
<tr>
<td align="left" valign="top">Medicare</td>
<td align="center" valign="top">127 (25.4)</td>
</tr>
<tr>
<td align="left" valign="top">Private insurance</td>
<td align="center" valign="top">181 (36.2)</td>
</tr>
<tr>
<td align="left" valign="top">No insurance</td>
<td align="center" valign="top">91 (18.2)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Education<sup>2</sup></td>
</tr>
<tr>
<td align="left" valign="top">Less than high school</td>
<td align="center" valign="top">119 (23.9)</td>
</tr>
<tr>
<td align="left" valign="top">High school graduate or more</td>
<td align="center" valign="top">380 (76.2)</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Transportation</td>
</tr>
<tr>
<td align="left" valign="top">Drove themselves to screening</td>
<td align="center" valign="top">371 (74.2)</td>
</tr>
<tr>
<td align="left" valign="top">Someone else drove them, public transportation, or walked<sup>3</sup></td>
<td align="center" valign="top">129 (25.8)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><sup>1</sup>Other included American Indian or Alaskan Native (<italic>N</italic>&#x202F;=&#x202F;1) and multiracial (<italic>N</italic>&#x202F;=&#x202F;13).</p>
<p><sup>2One person declined to provide education information.</sup></p>
<p><sup>3119 participants had someone else drive them, 2 used public transportation, and 8 walked.</sup></p>
</table-wrap-foot>
</table-wrap>
<p>NEI VFQ-9 scores differed with respect to several demographic characteristics (<xref ref-type="table" rid="tab3">Table 3</xref>) adjusting each variable for all the other variables in <xref ref-type="table" rid="tab3">Table 3</xref>. Women had lower scores than men; however, this difference was modest at 3 points. Several characteristics led to a more substantial difference in scores. Those who were unemployed or unable to work had on average 5 points lower than those who worked or were retired; those who had no health insurance had on average 3&#x2013;4 points lower than the other insurance categories. Persons who had someone else drive them, walked, or used public transportation to attend the screening visit had scores 5 points lower than those who drove themselves. Marital status had no impact on VFQ-9 scores. <xref ref-type="fig" rid="fig1">Figure 1</xref> shows the distribution of VFQ-9 composite scores (expressed as a percentage) stratified by the three FQHC clinic.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Visual Function Questionnaire &#x2013; 9 (VFQ-9) total score stratified by demographic characteristics including adjustments for other demographic variables.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top"><italic>n</italic> (%)</th>
<th align="center" valign="top">Mean VFQ-9 total score<break/>(standard deviation)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
<th align="center" valign="top">Adjusted mean VFQ-9 total score</th>
<th align="center" valign="top">Adjusted <italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Age, years</td>
<td colspan="2"/>
<td align="center" valign="top">0.005</td>
<td/>
<td align="center" valign="top">0.9463</td>
</tr>
<tr>
<td align="left" valign="top">18&#x2013;39</td>
<td align="center" valign="top">43 (8.6)</td>
<td align="center" valign="top">84.3 (14.5)</td>
<td rowspan="3"/>
<td align="center" valign="top">80.1</td>
<td rowspan="3"/>
</tr>
<tr>
<td align="left" valign="top">40&#x2013;59</td>
<td align="center" valign="top">247 (49.4)</td>
<td align="center" valign="top">80.4 (14.2)</td>
<td align="center" valign="top">79.4</td>
</tr>
<tr>
<td align="left" valign="top">&#x2265; 60</td>
<td align="center" valign="top">210 (42.0)</td>
<td align="center" valign="top">84.4 (12.9)</td>
<td align="center" valign="top">79.5</td>
</tr>
<tr>
<td colspan="3"/>
<td align="center" valign="top">Age-adjusted <italic>p</italic>-value</td>
<td colspan="2"/>
</tr>
<tr>
<td align="left" valign="top">Gender</td>
<td align="center" valign="top">178 (35.6)</td>
<td/>
<td align="center" valign="top">0.005</td>
<td/>
<td align="center" valign="top">0.0136</td>
</tr>
<tr>
<td align="left" valign="top">Men</td>
<td align="center" valign="top">322 (64.4)</td>
<td align="center" valign="top">84.8 (12.7)</td>
<td rowspan="2"/>
<td align="center" valign="top">81.2</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">Women</td>
<td/>
<td align="center" valign="top">81.1 (14.2)</td>
<td align="center" valign="top">78.1</td>
</tr>
<tr>
<td align="left" valign="top">Race</td>
<td colspan="2"/>
<td align="center" valign="top">0.013</td>
<td/>
<td align="center" valign="top">0.1749</td>
</tr>
<tr>
<td align="left" valign="top">African American</td>
<td align="center" valign="top">228 (45.6)</td>
<td align="center" valign="top">81.2 (13.7)</td>
<td rowspan="3"/>
<td align="center" valign="top">81.6</td>
<td rowspan="3"/>
</tr>
<tr>
<td align="left" valign="top">White persons</td>
<td align="center" valign="top">258 (51.6)</td>
<td align="center" valign="top">83.9 (13.0)</td>
<td align="center" valign="top">82.0</td>
</tr>
<tr>
<td align="left" valign="top">Other</td>
<td align="center" valign="top">14 (2.8)</td>
<td align="center" valign="top">75.1 (23.4)</td>
<td align="center" valign="top">75.4</td>
</tr>
<tr>
<td align="left" valign="top">Employment</td>
<td colspan="2"/>
<td align="center" valign="top">&#x003C;0.0001</td>
<td/>
<td align="center" valign="top">0.0068</td>
</tr>
<tr>
<td align="left" valign="top">Employed full- or part-time</td>
<td align="center" valign="top">171 (34.2)</td>
<td align="center" valign="top">85.7 (11.6)</td>
<td rowspan="3"/>
<td align="center" valign="top">81.4</td>
<td rowspan="3"/>
</tr>
<tr>
<td align="left" valign="top">Retired</td>
<td align="center" valign="top">136 (27.2)</td>
<td align="center" valign="top">85.0 (12.4)</td>
<td align="center" valign="top">80.1</td>
</tr>
<tr>
<td align="left" valign="top">Unemployed or unable to work</td>
<td align="center" valign="top">193 (38.6)</td>
<td align="center" valign="top">77.8 (15.2)</td>
<td align="center" valign="top">76.0</td>
</tr>
<tr>
<td align="left" valign="top">Marital status</td>
<td colspan="2"/>
<td align="center" valign="top">0.606</td>
<td/>
<td align="center" valign="top">0.7308</td>
</tr>
<tr>
<td align="left" valign="top">Married or domestic partnership</td>
<td align="center" valign="top">255 (51.0)</td>
<td align="center" valign="top">82.9 (13.3)</td>
<td rowspan="3"/>
<td align="center" valign="top">79.0</td>
<td rowspan="3"/>
</tr>
<tr>
<td align="left" valign="top">Divorced, separated, or single</td>
<td align="center" valign="top">190 (38.0)</td>
<td align="center" valign="top">81.5 (14.2)</td>
<td align="center" valign="top">79.5</td>
</tr>
<tr>
<td align="left" valign="top">Widowed</td>
<td align="center" valign="top">55 (11.0)</td>
<td align="center" valign="top">83.5 (14.6)</td>
<td align="center" valign="top">80.5</td>
</tr>
<tr>
<td align="left" valign="top">Health insurance</td>
<td colspan="2"/>
<td align="center" valign="top">&#x003C;0.0001</td>
<td/>
<td align="center" valign="top">0.0125</td>
</tr>
<tr>
<td align="left" valign="top">Medicaid</td>
<td align="center" valign="top">101 (20.2)</td>
<td align="center" valign="top">78.9 (15.4)</td>
<td rowspan="4"/>
<td align="center" valign="top">79.4</td>
<td rowspan="4"/>
</tr>
<tr>
<td align="left" valign="top">Medicare</td>
<td align="center" valign="top">127 (25.4)</td>
<td align="center" valign="top">85.0 (10.7)</td>
<td align="center" valign="top">82.5</td>
</tr>
<tr>
<td align="left" valign="top">Private insurance</td>
<td align="center" valign="top">181 (36.2)</td>
<td align="center" valign="top">85.1 (12.2)</td>
<td align="center" valign="top">80.7</td>
</tr>
<tr>
<td align="left" valign="top">No insurance</td>
<td align="center" valign="top">91 (18.2)</td>
<td align="center" valign="top">77.5 (16.4)</td>
<td align="center" valign="top">76.0</td>
</tr>
<tr>
<td align="left" valign="top">Education</td>
<td colspan="2"/>
<td align="center" valign="top">0.003</td>
<td align="center" valign="top">78.7</td>
<td align="center" valign="top">0.1618</td>
</tr>
<tr>
<td align="left" valign="top">Less than high school</td>
<td align="center" valign="top">119 (23.9)</td>
<td align="center" valign="top">79.3 (14.5)</td>
<td rowspan="2"/>
<td align="center" valign="top">80.7</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">High school graduate or more</td>
<td align="center" valign="top">380 (76.2)</td>
<td align="center" valign="top">83.4 (13.4)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">Transportation</td>
<td colspan="2"/>
<td align="center" valign="top">&#x003C;0.0001</td>
<td align="center" valign="top">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">Drove themselves to screening</td>
<td align="center" valign="top">371 (74.2)</td>
<td align="center" valign="top">84.7 (11.8)</td>
<td rowspan="2"/>
<td align="center" valign="top">83.0</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">Someone else drove them, public transportation, or walked</td>
<td align="center" valign="top">129 (25.8)</td>
<td align="center" valign="top">75.9 (16.7)</td>
<td align="center" valign="top">78.7</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>The distribution of VFQ-9 composite scores (expressed as a percentage) stratified by the three FQHC clinics.</p>
</caption>
<graphic xlink:href="fmed-12-1498413-g001.tif"/>
</fig>
<p>The largest impacts on VFQ-9 scores in terms of self-reported eye conditions were for blurry vision, double vision, and diabetic retinopathy, with these conditions lowering the score by about 7 to 13 points depending on the condition (<xref ref-type="table" rid="tab4">Table 4</xref>). Other conditions had more modest impacts in lowering scores, including glaucoma or glaucoma suspect status, dry eye, and floaters, lowering scores by approximately 3 points. Self-reported high eye pressure, cataract, and refractive error had no impact on VFQ-9 scores.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Visual Function Questionnaire &#x2013; 9 (VFQ-9) total score stratified by self-reported eye conditions.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top"><italic>n</italic> (%)</th>
<th align="center" valign="top">Mean VFQ-9 total score<break/>(standard deviation)</th>
<th align="center" valign="top">Age-adjusted <italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Glaucoma or glaucoma suspect</td>
<td colspan="2"/>
<td align="center" valign="top">0.024</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">70 (14.0)</td>
<td align="center" valign="top">79.0 (13.3)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">430 (86.0)</td>
<td align="center" valign="top">83.0 (14.0)</td>
</tr>
<tr>
<td align="left" valign="top">High eye pressure</td>
<td colspan="2"/>
<td align="center" valign="top">0.191</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">51 (89.8)</td>
<td align="center" valign="top">80.0 (13.0)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">449 (10.2)</td>
<td align="center" valign="top">82.7 (13.9)</td>
</tr>
<tr>
<td align="left" valign="top">Cataract</td>
<td colspan="2"/>
<td align="center" valign="top">0.121</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">106 (21.2)</td>
<td align="center" valign="top">81.0 (14.2)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">394 (78.8)</td>
<td align="center" valign="top">82.8 (13.7)</td>
</tr>
<tr>
<td align="left" valign="top">Diabetic retinopathy</td>
<td colspan="2"/>
<td align="center" valign="top">0.025</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">20 (4.0)</td>
<td align="center" valign="top">75.8 (11.8)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">480 (96.0)</td>
<td align="center" valign="top">82.7 (13.8)</td>
</tr>
<tr>
<td align="left" valign="top">Age-related macular degeneration</td>
<td colspan="2"/>
<td align="center" valign="top">0.527</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">10 (2.0)</td>
<td align="center" valign="top">80.3 (12.4)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">490 (98.0)</td>
<td align="center" valign="top">82.5 (13.8)</td>
</tr>
<tr>
<td align="left" valign="top">Refractive error</td>
<td colspan="2"/>
<td align="center" valign="top">0.520</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">45 (9.0)</td>
<td align="center" valign="top">82.3 (13.5)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">455 (91.0)</td>
<td align="center" valign="top">83.3 (16.5)</td>
</tr>
<tr>
<td align="left" valign="top">Dry eye</td>
<td colspan="2"/>
<td align="center" valign="top">0.023</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">152 (30.4)</td>
<td align="center" valign="top">80.4 (14.2)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">348 (69.6)</td>
<td align="center" valign="top">83.3 (13.5)</td>
</tr>
<tr>
<td align="left" valign="top">Blurry vision</td>
<td colspan="2"/>
<td align="center" valign="top">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">188 (37.6)</td>
<td align="center" valign="top">76.7 (13.8)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">312 (62.4)</td>
<td align="center" valign="top">85.9 (12.6)</td>
</tr>
<tr>
<td align="left" valign="top">Double vision</td>
<td colspan="2"/>
<td align="center" valign="top">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">39 (7.8)</td>
<td align="center" valign="top">70.1 (14.2)</td>
<td rowspan="2"/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">461 (92.2)</td>
<td align="center" valign="top">83.5 (13.3)</td>
</tr>
<tr>
<td align="left" valign="top">Floaters</td>
<td colspan="3"/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">131 (26.2)</td>
<td align="center" valign="top">80.4 (12.7)</td>
<td align="center" valign="top">0.040</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">369 (73.8)</td>
<td align="center" valign="top">83.2 (14.1)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>When examining which participant demographics accounted for the VFQ-9 score, transportation and insurance type/status were the only items chosen in stepwise regression and accounted for 11.4% of variance (AICC&#x202F;=&#x202F;3,065, adjusted <italic>R</italic><sup>2</sup>&#x202F;=&#x202F;0.114). For models examining the impact of self-reported eye conditions on VFQ-9, blurry vision and double vision accounted for 13% of variance of the VFQ-9 and were the eye conditions meeting criteria in stepwise regression (AICC&#x202F;=&#x202F;3,057, adjusted <italic>R</italic><sup>2</sup>&#x202F;=&#x202F;0.13). Modeling of all factors together revealed that whether one was a driver, insurance type/status, self-reported glaucoma or glaucoma suspect, self-reported blurry vision, and self-reported double vision most accounted for the VFQ-9 score. These items comprised 21.8% of the variance of the composite measure and produced the lowest AICC of the stepwise models (AICC&#x202F;=&#x202F;3,006, adjusted <italic>R</italic><sup>2</sup>&#x202F;=&#x202F;0.218).</p>
<p><xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref> presents the demographic characteristics stratified by the three FQHC clinics. Clinic 1 had a higher percentage of patients &#x2265;60&#x202F;years of age than the other two clinics. Clinics 1 and 2 had a higher percentage of African American patients than did Clinic 3. Clinic 1 had a lower percentage of patients who were employed compared to Clinics 2 and 3. Clinic 3 had a higher percentage of patients who were married or in domestic partnerships, and Clinic 2 had a higher percentage of patients who were divorced separated, or single, compared to the other clinics. Clinic 1 had a higher percentage of patients on Medicaid or Medicare than the other clinics. Clinic 2 had a higher percentage of patients with private health insurance. Clinic 3 had a higher percentage of clinics with no health insurance. Clinic 1 had a higher percentage of patients who had less than a high school education.</p>
</sec>
<sec sec-type="discussion" id="sec11">
<label>4</label>
<title>Discussion</title>
<p>The current study which focused on three FQHCs in a lower-income, rural region of Alabama found that VFQ-9 composite scores averaged 82, indicating a minor-to-moderate impairment in vision-targeted quality of life. Only one previous study examined the performance of the VFQ-9 in patients seeking at an eye screening at a FQHC located in Flint, Michigan (<xref ref-type="bibr" rid="ref12">12</xref>). Like the current study, this FQHC is situated in a low-income community with a high percentage of African Americans, but this region is urban rather than rural as in our study. Their average VFQ-9 composite score was very similar to that reported herein, i.e., 79. The VFQ-9 has not been extensively used in the literature so comparison to other studies is challenging, especially since studies using the VFQ-9 address specific ophthalmic conditions (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref14">14</xref>). During a follow-up visit in the Study on Osteoporotic Fractures (<xref ref-type="bibr" rid="ref10">10</xref>), a comprehensive eye examination was included along with administration of the VFQ-9. The study included 5,482 women of which 88% were white persons, which is in sharp contrast to the demographics of the current study&#x2019;s participants, one-third of which were men and approximately half were African American. We note that average scores in the current study with a large percentage of African Americans from lower-income, rural regions had average scores about 10 points worse than the sample from the Study on Osteoporotic Fractures. Thus, it is important to identify factors that impact VFQ-9 scores among patients from FQHCs.</p>
<p>Although the VFQ-9 is a vision-targeted, health-related quality of life measure, the literature on the parent VFQ-25 questionnaire indicates that non-vision-related issues impact VFQ scores (e.g., regional economy (<xref ref-type="bibr" rid="ref15">15</xref>), health resources available in the region (<xref ref-type="bibr" rid="ref15">15</xref>), education (<xref ref-type="bibr" rid="ref16">16</xref>), income (<xref ref-type="bibr" rid="ref17">17</xref>)). In the current study the most parsimonious model of VFQ-9 scores included two non-visual characteristics. Having no health insurance lowered the VFQ-9 score. In addition, being a driver and having access to a vehicle for transportation to the FQHC appointment increased the VFQ-9 score, as compared to those participants who depended on a ride from another person, took public transportation, or walked. Research indicates being a driver allows for a level of freedom and independence that is critical for social engagement and participation, and thus, it is not surprising that it contributes to quality of life (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>). In fact several prospective studies have shown that driving cessation is associated with incident depression (<xref ref-type="bibr" rid="ref20 ref21 ref22">20&#x2013;22</xref>) and also makes it more challenging to seek out medical care (<xref ref-type="bibr" rid="ref23">23</xref>). Another factor which compounds the issue is the rurality of participants showing that those in nonurban areas have increased transportation challenges resulting in poorer healthcare access (<xref ref-type="bibr" rid="ref24">24</xref>).</p>
<p>The final model accounting for the largest proportion of variance of the VFQ-9 given our selection criterion also included some self-reported eye conditions, namely glaucoma or glaucoma suspect, blurry vision, and double vision. Both glaucoma and glaucoma suspect status have been widely reported to be associated with reduced vision-targeted health related quality of life (<xref ref-type="bibr" rid="ref25 ref26 ref27">25&#x2013;27</xref>). Since our sampling strategy targeted patients who were at-risk for glaucoma associated disease, it is not surprising that self-reported glaucoma and glaucoma suspect were variables in the final model. The prior literature also suggests that many of the other eye conditions we asked about, particularly AMD, cataract, and diabetic retinopathy, impact quality of life; however, the current study did not show they had a significant impact VFQ-9 scores. It could be that these conditions were not severe enough to impact daily experience but this remains unknown. The limited number of persons found with AMD or diabetic retinopathy might also explain the lack of association. Patients reporting blurry vision or double vision also were part of the final model, both of which can be caused by many different etiologies.</p>
<p>Strengths of the current study consist of its focus on understanding vision-targeted, health-related quality of life in rural FQHCs, a unique federally-funded healthcare delivery model in the US designed for medically underserved areas and populations. Only one other study has examined vision-targeted quality of life in an FQHC, and the current and previous study are in agreement that the VFQ-9 scores are very similar, showing on average moderate impairment in quality of life. The sample size of the current study (i.e., 500) is large and targeted at people who were at risk for glaucoma. We also sought to identify demographic characteristics as well as self-reported eye conditions that predicted FQHC scores. Study limitations must also be acknowledged. Our study focused on one FQHC organization using three clinics, so generalizability is unknown. However, we are now embarking on a new telemedicine program in other FQHC clinics in Alabama, using a very similar protocol to examine generalizability. While we examined many demographic variables in terms of their impact on VFQ-9 scores, we did not include income, although persons seeking care from FQHCs typically have lower incomes. There were some demographic differences among the three clinics. We would like to emphasize that the eye conditions we studied were self-reported, not ophthalmologist diagnosed, however we are currently collecting this data in our ongoing eye screening program where the VFQ-9 is also being administered.</p>
<p>In summary, we have shown that vision-targeted, health-related quality of life is moderately reduced in patients seeking care at FQHCs in rural Alabama. Our program focused on patients who had risk factors for glaucoma associated disorders. The best-fitting model of predictors for VFQ-9 scores were self-reported glaucoma or glaucoma suspect, blurry vision, double vision, being a driver, and having no health insurance. The VFQ-9 is a good candidate for a vision-target health-related quality of life measure for future eye health interventions to be implemented at rural FQHCs.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec12">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec13">
<title>Ethics statement</title>
<p>The studies involving humans were approved by University of Alabama at Birmingham. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="sec14">
<title>Author contributions</title>
<p>TS: Formal analysis, Writing &#x2013; review &#x0026; editing. GM: Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Writing &#x2013; review &#x0026; editing. LR: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing &#x2013; review &#x0026; editing. CG: Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing &#x2013; review &#x0026; editing. CO: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec15">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Centers for Disease Control and Prevention (1U01DP006441), the National Eye Institute/National Institutes of Health (P30EY03039), EyeSight Foundation of Alabama, and Research to Prevent Blindness.</p>
</sec>
<sec sec-type="COI-statement" id="sec16">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec17">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec18">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2025.1498413/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmed.2025.1498413/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Teutsch</surname> <given-names>SM</given-names></name> <name><surname>McCoy</surname> <given-names>MA</given-names></name> <name><surname>Woodbury</surname> <given-names>RB</given-names></name> <name><surname>Welp</surname> <given-names>A</given-names></name></person-group>. <source>Making eye health a population health imperative: Vision for tomorrow</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name> (<year>2016</year>).</citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawagushi</surname> <given-names>A</given-names></name> <name><surname>Sharafeldin</surname> <given-names>N</given-names></name> <name><surname>Sundaram</surname> <given-names>A</given-names></name> <name><surname>Campbell</surname> <given-names>S</given-names></name> <name><surname>Tennant</surname> <given-names>M</given-names></name> <name><surname>Rudnisky</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Tele-ophthalmology for age-related macular degeneration and diabeteic retinnopathy screening: a systematic review and meta-analysis</article-title>. <source>Telemed J E Health</source>. (<year>2018</year>) <volume>24</volume>:<fpage>301</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1089/tmj.2017.0100</pub-id>, PMID: <pub-id pub-id-type="pmid">28783458</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Modjtahedi</surname> <given-names>BS</given-names></name> <name><surname>Chu</surname> <given-names>K</given-names></name> <name><surname>Luong</surname> <given-names>TQ</given-names></name> <name><surname>Hsu</surname> <given-names>C</given-names></name> <name><surname>Mattox</surname> <given-names>C</given-names></name> <name><surname>Lee</surname> <given-names>PP</given-names></name> <etal/></person-group>. <article-title>Two-year outcomes of a pilot glaucoma suspect telemedicine monitoring program</article-title>. <source>Clin Ophthalmol</source>. (<year>2018</year>) <volume>12</volume>:<fpage>2095</fpage>&#x2013;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.2147/OPTH.S171263</pub-id>, PMID: <pub-id pub-id-type="pmid">30410304</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhaskar</surname> <given-names>S</given-names></name> <name><surname>Bradley</surname> <given-names>S</given-names></name> <name><surname>Chattu</surname> <given-names>VK</given-names></name> <name><surname>Adiseesh</surname> <given-names>A</given-names></name> <name><surname>Nurtazani</surname> <given-names>A</given-names></name> <name><surname>Kyrykbayeva</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Telemedicine across the globe - position paper from the COVID-19 pandemic health system resilience PROGRAM (REPROGRAM) Internatinal consortium (part 1)</article-title>. <source>Front Public Health</source>. (<year>2020</year>) <volume>8</volume>:<fpage>556720</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2020.556720</pub-id>, PMID: <pub-id pub-id-type="pmid">33178656</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owsley</surname> <given-names>C</given-names></name> <name><surname>Swain</surname> <given-names>TA</given-names></name> <name><surname>McGwin</surname> <given-names>G</given-names> <suffix>Jr</suffix></name> <name><surname>Nghiem</surname> <given-names>VTH</given-names></name> <name><surname>Register</surname> <given-names>S</given-names></name> <name><surname>Asif</surname> <given-names>IM</given-names></name> <etal/></person-group>. <article-title>Alabama screening and intervention for Glaucoma and eye health through telemedicine (AL-SIGHT): baseline results</article-title>. <source>Am J Ophthalmol</source>. (<year>2023</year>) <volume>257</volume>:<fpage>66</fpage>&#x2013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajo.2023.09.001</pub-id>, PMID: <pub-id pub-id-type="pmid">37683821</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>JD</given-names></name> <name><surname>Khawaja</surname> <given-names>AP</given-names></name> <name><surname>Weizer</surname> <given-names>JS</given-names></name></person-group>. <article-title>Glaucoma in adults &#x2014; screening, diagnosis, and management</article-title>. <source>JAMA</source>. (<year>2021</year>) <volume>325</volume>:<fpage>164</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.21899</pub-id>, PMID: <pub-id pub-id-type="pmid">33433580</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aladuwaka</surname> <given-names>S</given-names></name> <name><surname>Alagan</surname> <given-names>R</given-names></name> <name><surname>Singh</surname> <given-names>R</given-names></name> <name><surname>Mishra</surname> <given-names>M</given-names></name></person-group>. <article-title>Health burdens and SES in Alabama: using geographic information system to examine prostate Cancer health disparity</article-title>. <source>Cancers</source>. (<year>2022</year>) <volume>14</volume>:<fpage>4824</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers14194824</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangione</surname> <given-names>CM</given-names></name> <name><surname>Berry</surname> <given-names>S</given-names></name> <name><surname>Spritzer</surname> <given-names>K</given-names></name> <name><surname>Janz</surname> <given-names>NK</given-names></name> <name><surname>Klein</surname> <given-names>R</given-names></name> <name><surname>Owsley</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Identifying the content area for the 51-item National eye Institute visual function questionnaire (NEIVFQ-51)</article-title>. <source>Arch Ophthalmol</source>. (<year>1998</year>) <volume>116</volume>:<fpage>227</fpage>&#x2013;<lpage>33</lpage>. PMID: <pub-id pub-id-type="pmid">9488276</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangione</surname> <given-names>CM</given-names></name> <name><surname>Lee</surname> <given-names>PP</given-names></name> <name><surname>Gutierrez</surname> <given-names>PR</given-names></name> <name><surname>Spritzer</surname> <given-names>K</given-names></name> <name><surname>Berry</surname> <given-names>S</given-names></name> <name><surname>Hays</surname> <given-names>RD</given-names></name> <etal/></person-group>. <article-title>Development of the 25-item National eye Institute visual function questionnaire</article-title>. <source>Arch Ophthalmol</source>. (<year>2001</year>) <volume>119</volume>:<fpage>1050</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archopht.119.7.1050</pub-id>, PMID: <pub-id pub-id-type="pmid">11448327</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kodjebacheva</surname> <given-names>G</given-names></name> <name><surname>Coleman</surname> <given-names>AL</given-names></name> <name><surname>Ensrud</surname> <given-names>KE</given-names></name> <name><surname>Cauley</surname> <given-names>JA</given-names></name> <name><surname>Yu</surname> <given-names>F</given-names></name> <name><surname>Stone</surname> <given-names>KL</given-names></name> <etal/></person-group>. <article-title>Reliability and validity of abbreviated surveys derived from the National eye Institute visual function questionnaire</article-title>. <source>Am J Ophthalmology</source>. (<year>2010</year>) <volume>149</volume>:<fpage>330</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajo.2009.09.008</pub-id>, PMID: <pub-id pub-id-type="pmid">20103058</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Mangione</surname> <given-names>CM</given-names></name></person-group>. <article-title>NEI VFQ-25 scoring algorithm. National Eye Institute, National Institutes of Health</article-title>. Available at: <ext-link xlink:href="https://www.nei.nih.gov/sites/default/files/2019-06/manual_cm2000.pdf" ext-link-type="uri">https://www.nei.nih.gov/sites/default/files/2019-06/manual_cm2000.pdf</ext-link>. (<year>2000</year>).</citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newman-Casey</surname> <given-names>PA</given-names></name> <name><surname>Niziol</surname> <given-names>LM</given-names></name> <name><surname>Elam</surname> <given-names>AR</given-names></name> <name><surname>Bicket</surname> <given-names>AK</given-names></name> <name><surname>Killeen</surname> <given-names>O</given-names></name> <name><surname>John</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Michigan screening and intervention for Glaucoma and eye health through telemedicine program: first year outcomes and implementation costs</article-title>. <source>Am J Ophthalmol</source>. (<year>2023</year>) <volume>251</volume>:<fpage>43</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajo.2023.02.026</pub-id>, PMID: <pub-id pub-id-type="pmid">36906094</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tuohy</surname> <given-names>MM</given-names></name> <name><surname>Niziol</surname> <given-names>LM</given-names></name> <name><surname>Mian</surname> <given-names>S</given-names></name> <name><surname>Ballouz</surname> <given-names>D</given-names></name> <name><surname>Bosch</surname> <given-names>D</given-names></name> <name><surname>Woodward</surname> <given-names>MA</given-names></name></person-group>. <article-title>Patient reported outcomes in microbial keratitis</article-title>. <source>Cornea</source>. (<year>2021</year>) <volume>40</volume>:<fpage>19</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ICO.0000000000002362</pub-id>, PMID: <pub-id pub-id-type="pmid">32482958</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname> <given-names>GE</given-names></name> <name><surname>Titus</surname> <given-names>M</given-names></name> <name><surname>Stein</surname> <given-names>JD</given-names></name> <name><surname>Meijome</surname> <given-names>TE</given-names></name> <name><surname>Mian</surname> <given-names>SI</given-names></name> <name><surname>Woodward</surname> <given-names>MA</given-names></name></person-group>. <article-title>Patient-reported outcomes after corneal transplantation</article-title>. <source>Cornea</source>. (<year>2021</year>) <volume>40</volume>:<fpage>1316</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ICO.0000000000002690</pub-id>, PMID: <pub-id pub-id-type="pmid">33758138</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Zhao</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Sun</surname> <given-names>M</given-names></name> <name><surname>Chen</surname> <given-names>DZ</given-names></name> <etal/></person-group>. <article-title>The association between socioeconomic factors and visual function among patients with age-related cataract</article-title>. <source>J Ophthalmol</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/7236214</pub-id>, PMID: <pub-id pub-id-type="pmid">33335783</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jammal</surname> <given-names>HM</given-names></name> <name><surname>Khader</surname> <given-names>Y</given-names></name> <name><surname>Kanaan</surname> <given-names>SF</given-names></name> <name><surname>Al-Dwairi</surname> <given-names>R</given-names></name> <name><surname>Mohidat</surname> <given-names>H</given-names></name> <name><surname>Al-Omari</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>The effect of visual impairment and its severity on vision-related and health-related qualify of life in Jordan: a comparative cross-sectional study</article-title>. <source>J Multidiscip Healthc</source>. (<year>2023</year>) <volume>16</volume>:<fpage>3043</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.2147/JMDH.S431159</pub-id>, PMID: <pub-id pub-id-type="pmid">37873536</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broman</surname> <given-names>AT</given-names></name> <name><surname>Munoz</surname> <given-names>B</given-names></name> <name><surname>West</surname> <given-names>SK</given-names></name> <name><surname>Rodriguez</surname> <given-names>J</given-names></name> <name><surname>Sanchez</surname> <given-names>R</given-names></name> <name><surname>Snyder</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2001</year>) <volume>42</volume>:<fpage>606</fpage>&#x2013;<lpage>13</lpage>. PMID: <pub-id pub-id-type="pmid">11222517</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owsley</surname> <given-names>C</given-names></name></person-group>. <article-title>Driving mobility, older adults, and quality of life</article-title>. <source>Gerontechnology</source>. (<year>2002</year>) <volume>1</volume>:<fpage>220</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.4017/gt.2002.01.04.002.00</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donoghue</surname> <given-names>OA</given-names></name> <name><surname>McGarrigle</surname> <given-names>CA</given-names></name> <name><surname>Kenny</surname> <given-names>RA</given-names></name></person-group>. <article-title>Who&#x2019;s in the driver&#x2019;s seat? Impact on social participation and psychosocial wellbeing in adults aged 50 and over</article-title>. <source>Transp Res Part F: Traffic Psychol Behav</source>. (<year>2019</year>) <volume>64</volume>:<fpage>522</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.trf.2019.06.010</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonda</surname> <given-names>SJ</given-names></name> <name><surname>Wallace</surname> <given-names>RB</given-names></name> <name><surname>Herzog</surname> <given-names>AR</given-names></name></person-group>. <article-title>Changes in driving patterns and worsening depressive symptoms among older adults</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. (<year>2001</year>) <volume>56</volume>:<fpage>S343</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1093/geronb/56.6.S343</pub-id>, PMID: <pub-id pub-id-type="pmid">11682595</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marottoli</surname> <given-names>RA</given-names></name> <name><surname>de Leon</surname> <given-names>CFM</given-names></name> <name><surname>Glass</surname> <given-names>TA</given-names></name> <name><surname>Williams</surname> <given-names>CS</given-names></name> <name><surname>Cooney</surname> <given-names>LM</given-names> <suffix>Jr</suffix></name> <name><surname>Berkman</surname> <given-names>LF</given-names></name> <etal/></person-group>. <article-title>Driving cessation and increased depressive symptoms: prospective evidence from the New Haven EPESE</article-title>. <source>J Am Geriatr Soc</source>. (<year>1997</year>) <volume>45</volume>:<fpage>202</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.1997.tb04508.x</pub-id>, PMID: <pub-id pub-id-type="pmid">9033520</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ragland</surname> <given-names>DR</given-names></name> <name><surname>Satariano</surname> <given-names>WA</given-names></name> <name><surname>MacLeod</surname> <given-names>KE</given-names></name></person-group>. <article-title>Driving cessation and increased depressive symptoms</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. (<year>2005</year>) <volume>60</volume>:<fpage>399</fpage>&#x2013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/60.3.399</pub-id>, PMID: <pub-id pub-id-type="pmid">15860482</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owsley</surname> <given-names>C</given-names></name> <name><surname>McGwin</surname> <given-names>G</given-names></name> <name><surname>Scilley</surname> <given-names>K</given-names></name> <name><surname>Girkin</surname> <given-names>CA</given-names></name> <name><surname>Phillips</surname> <given-names>JM</given-names></name> <name><surname>Searcey</surname> <given-names>K</given-names></name></person-group>. <article-title>Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2006</year>) <volume>47</volume>:<fpage>2797</fpage>&#x2013;<lpage>802</lpage>. doi: <pub-id pub-id-type="doi">10.1167/iovs.06-0107</pub-id>, PMID: <pub-id pub-id-type="pmid">16799016</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname> <given-names>MK</given-names></name> <name><surname>McDonald</surname> <given-names>NC</given-names></name> <name><surname>Holmes</surname> <given-names>GM</given-names></name></person-group>. <article-title>Transportation barriers to health care in the United States: findings from the National Health Interview Survey</article-title>. <source>Am J Public Health</source>. (<year>2020</year>) <volume>110</volume>:<fpage>815</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.2105/AJPH.2020.305579</pub-id>, PMID: <pub-id pub-id-type="pmid">32298170</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringsdorf</surname> <given-names>L</given-names></name> <name><surname>McGwin</surname> <given-names>G</given-names> <suffix>Jr</suffix></name> <name><surname>Owsley</surname> <given-names>C</given-names></name></person-group>. <article-title>Visual field defects and vision-specific health-related quality of life in African Americans and whites with glaucoma</article-title>. <source>J Glaucoma</source>. (<year>2006</year>) <volume>15</volume>:<fpage>414</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.ijg.0000212252.72207.c2</pub-id>, PMID: <pub-id pub-id-type="pmid">16988604</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Latif</surname> <given-names>K</given-names></name> <name><surname>Nishida</surname> <given-names>T</given-names></name> <name><surname>Moghimi</surname> <given-names>S</given-names></name> <name><surname>Weinreb</surname> <given-names>RN</given-names></name></person-group>. <article-title>Quality of life in glaucoma</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>. (<year>2023</year>) <volume>261</volume>:<fpage>3023</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00417-023-06050-z</pub-id>, PMID: <pub-id pub-id-type="pmid">37017741</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khachatryan</surname> <given-names>N</given-names></name> <name><surname>Pistilli</surname> <given-names>M</given-names></name> <name><surname>Maguire</surname> <given-names>MG</given-names></name> <name><surname>Chang</surname> <given-names>AY</given-names></name> <name><surname>Samuels</surname> <given-names>MR</given-names></name> <name><surname>Mulvihill</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>A review of studies of the association of vision-related quality of life with measures of visual function and structure in patients with glaucoma in the United States</article-title>. <source>Ophthalmic Epidemiol</source>. (<year>2021</year>) <volume>28</volume>:<fpage>265</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09286586.2020.1863992</pub-id>, PMID: <pub-id pub-id-type="pmid">33530788</pub-id></citation></ref>
</ref-list>
</back>
</article>